| 1 |
中华医学会血液学分会红细胞疾病(贫血)学组. 阵发性睡眠性血红蛋白尿症诊断与治疗中国专家共识[J]. 中华血液学杂志，2013, 34(3): 276-279.
|
| 2 |
中华医学会血液学分会红细胞疾病(贫血)学组. 再生障碍性贫血诊断与治疗中国专家共识(2017年版)[J]. 中华血液学杂志，2017, 38(1): 1-5.
|
| 3 |
Bacigalupo A, Soci G, Hamladji RM, et al. Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis[J]. Haematologica, 2015, 100(5):696-702.
|
| 4 |
Dufour C, Veys P, Carraro E, et al. Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT[J]. Br J Haematol, 2015, 171(4):585-594.
|
| 5 |
周健，张莉，符粤文，等. 无关供者造血干细胞移植治疗重型再生障碍性贫血29例的疗效分析[J]. 中华器官移植杂志，2017, 38(2):78-83.
|
| 6 |
Bacigalupo A, Socie G, Lanino E, et al. Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA working party[J]. Haematologica, 2010, 95(6): 976-982.
|
| 7 |
Pillai A, Hartford C, Wang C, et al. Favorable preliminary results using TLI/ATG-based immunomodulatory conditioning for matched unrelated donor allogeneic hematopoietic stem cell transplantation in pediatric severe aplastic anemia[J]. Pediatr Transplant, 2011, 15(6): 628-634.
|
| 8 |
Lewis SM, Dacie JV. The aplastic anaemia-paroxysmal nocturnal haemoglobinuria syndrome[J]. Br J Haematol, 1967, 13(2):236-251.
|
| 9 |
Parker C, Omine M, Richards S, et al. Diagnosis and management of paroxysmal nocturnal hemoglobinuria[J]. Blood, 2005, 106(12):3699-3709.
|
| 10 |
Loschi M, Porcher R, Barraco F, et al. Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment study[J]. Am J Hematol, 2016, 91(4): 366-370.
|
| 11 |
曹燕然，邵宗鸿，贾海蓉，等. DA或HA方案治疗难治复发性阵发性睡眠性血红蛋白尿症的初步观察[J]. 中华血液学杂志，2004, 25(4): 202-204.
|
| 12 |
谢小望，李辉，鹿晓煜，等. 低剂量HA方案治疗难治性、复发性AA-PNH综合症1例并文献复习[J]. 临床血液学杂志，2015, 28(11): 996-998.
|
| 13 |
Xu LP, Wang SQ, Wu DP, et al. Haplo-identical transplantation for acquired severe aplastic anaemia in a multicentre prospective study[J]. Br J Haematol, 2016, 175(2):265-274.
|
| 14 |
Xu LP, Jin S, Wang SQ, et al. Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched realted transplant[J]. J Hematol Oncol, 2017, 10(1):25.
|
| 15 |
Im HJ, Koh KN, Seo JJ. Haploidentical hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemia[J]. Korean J Pediatr, 2015, 58(6):199-205.
|
| 16 |
Clay J, Kulasekararaj AG, Potter V, et al. Nonmyeloablative peripheral blood haploidentical stem cell transplantation for refractory severe aplastic anemia[J]. Biol Blood Marrow Transplant, 2014, 20(11):1711-1716.
|
| 17 |
Gao L, Li Y, Zhang Y, et al. Long-term outcome of HLA-haploidentical hematopoietic SCT without in vitro T-cell depletion for adult severe aplastic anemia after modified conditioning and supportive therapy[J]. Bone Marrow Transplant, 2014, 49(4):519-524.
|
| 18 |
Yamei W, Rongmu L, Yongbin C, et al. Improved outcome of haploidentical transplantation in severe aplastic anemia using reduced-intensity fludarabinebased conditioning[J]. Oncotarget, 2017, 8(48):83817-83830.
|
| 19 |
Barker JN, Scaradavou A, Stevens CE. Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies[J]. Blood, 2010, 115(9):1843-1849.
|
| 20 |
Yamamolo H, Kato D, Uchida N, et al. Successful sustained engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with severe aplastic anemia[J]. Blood, 2011, 117(11):3240-3242.
|
| 21 |
Liu HL, Sun ZM, Geng LQ, et al. Unrelated cord blood transplantation for newly diagnosed patients with severe acquired aplastic anemia using a reduced-intensity conditioning: high graft rejection, but good survival[J]. Bone Marrow Transplant, 2012, 47(9):1186-1190.
|
| 22 |
刘立民，张彦明，周惠芬，等. 单倍型造血干细胞联合第三方脐血干细胞移植治疗重型再生障碍性贫血127例临床观察[J]. 中华血液血杂志，2018, 39(8):624-628.
|
| 23 |
夏晶，陈苏宁，陈佳，等. 单倍型造血干细胞移植治疗阵发性睡眠性血红蛋白尿症17例疗效和安全性研究[J]. 中华血液学杂志，2018, 39(11):904-907.
|
| 24 |
Socié G, Schrezenmeier H, Muus P, et al. Changing prognosis in paroxysmal nocturnal haemoglobinuria disease subcategories: an analysis of the International PNH Registry[J]. Intern Med J, 2016, 46(9):1044-1053.
|
| 25 |
Alvarado LJ, Huntsman HD, Cheng H, et al. Eltrombopag maintains human hematopoietic stem and progenitor cells under inflammatory conditions mediated by IFN-γ[J]. Blood, 2019, 133(19):2043-2055.
|
| 26 |
Fu H, Zhang X, Han T, et al. Eltrombopag is an effective and safe therapy for refractory thrombocytopenia after haploidentical hematopoietic stem cell transplantation[J]. Bone Marrow Transplant, 2019, 54(8): 1310-1318.
|
| 27 |
Liu X, Wu M, Peng Y, et al. Improvement in poor graft function after allogeneic hematopoietic stem cell transplantation upon administration of mesenchymal stem cells from third-party donors: a pilot prospective study[J]. Cell Transplant, 2014, 23(9):1087-1098.
|